Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naveen S Vasudev

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Current Opinion in Supportive and Palliative Care|July 31, 2010
Medical management of metastatic bone diseaseNaveen S Vasudev, Janet E Brown
Angiogenesis|February 1, 2014
Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directionsNaveen S Vasudev, Andrew R Reynolds
Clinical Medicine Insights. Oncology|November 16, 2011
Tyrosine kinase inhibitors in the treatment of advanced renal cell carcinoma: focus on pazopanibNaveen S Vasudev, James M G Larkin
Ecancermedicalscience|June 28, 2016
Letters of condolence: assessing attitudes and variability in practice amongst oncologists and palliative care doctors in YorkshireJessica S Hayward, Oluwatobi Makinde, Naveen S Vasudev
Clinical Biochemistry|December 12, 2012
Proteomics and the search for biomarkers for renal cancerRachel A Craven, Naveen S Vasudev, Rosamonde E Banks
BMC Medicine|September 29, 2012
Renal cancer biomarkers: the promise of personalized careNaveen S Vasudev, Peter J Selby, Rosamonde E Banks
Urology|February 9, 2020
AUTHOR REPLYNaveen S Vasudev, Peter J Selby, Rosamonde E Banks
European Biophysics Journal : EBJ|June 13, 2016
Transient receptor potential canonical 4 and 5 proteins as targets in cancer therapeuticsHannah J Gaunt, Naveen S Vasudev, David J Beech
BMJ (Clinical Research Ed.)|December 21, 2010
Febrile neutropeniaJay D Naik, Suren R K Sathiyaseelan, Naveen S Vasudev
The Journal of Biological Chemistry|January 24, 2013
Essential role for endocytosis in the growth factor-stimulated activation of ERK1/2 in endothelial cellsMorgane Gourlaouen, Jonathan C Welti, Naveen S Vasudev, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Current Opinion in Supportive and Palliative Care|July 31, 2010
Medical management of metastatic bone diseaseNaveen S Vasudev, Janet E Brown
Angiogenesis|February 1, 2014
Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directionsNaveen S Vasudev, Andrew R Reynolds
Clinical Medicine Insights. Oncology|November 16, 2011
Tyrosine kinase inhibitors in the treatment of advanced renal cell carcinoma: focus on pazopanibNaveen S Vasudev, James M G Larkin
Ecancermedicalscience|June 28, 2016
Letters of condolence: assessing attitudes and variability in practice amongst oncologists and palliative care doctors in YorkshireJessica S Hayward, Oluwatobi Makinde, Naveen S Vasudev
Clinical Biochemistry|December 12, 2012
Proteomics and the search for biomarkers for renal cancerRachel A Craven, Naveen S Vasudev, Rosamonde E Banks
BMC Medicine|September 29, 2012
Renal cancer biomarkers: the promise of personalized careNaveen S Vasudev, Peter J Selby, Rosamonde E Banks
Urology|February 9, 2020
AUTHOR REPLYNaveen S Vasudev, Peter J Selby, Rosamonde E Banks
European Biophysics Journal : EBJ|June 13, 2016
Transient receptor potential canonical 4 and 5 proteins as targets in cancer therapeuticsHannah J Gaunt, Naveen S Vasudev, David J Beech
BMJ (Clinical Research Ed.)|December 21, 2010
Febrile neutropeniaJay D Naik, Suren R K Sathiyaseelan, Naveen S Vasudev
The Journal of Biological Chemistry|January 24, 2013
Essential role for endocytosis in the growth factor-stimulated activation of ERK1/2 in endothelial cellsMorgane Gourlaouen, Jonathan C Welti, Naveen S Vasudev, et al.
Pageof 5